(Health-NewsWire.Net, December 08, 2017 ) According to the report North America Cervical Cancer Diagnostics and Therapeutics Market, published by Market Data Forecast, the North America market is projected to reach USD 1.5 billion by 2022, at a CAGR of 3.9% from 2017 to 2022.
Cervical cancers are diagnosed based on their classification on how they look under a microscope. Cervical pre-cancers are more frequent in occurrence than invasive cervical cancers.
Get a comprehensive overview of the North America Cervical Cancer Diagnostics and Therapeutics Market: http://marketdataforecast.com/market-reports/north-america-cervical-cancer-diagnostics-and-therapeutics-market-830/
North America Cervical Cancer Diagnostics and Therapeutics Market: Drivers & Restraints Growing number of pipeline cervical cancer screening tests, savoury government policies and proactive involvement in the prevention and treatment of cancer are the primary drivers of market growth. Hefty treatment costs along with unpredictable reimbursement situation are the primary restraints of this market.
Get accurate market forecast and analysis on the North America Cervical Cancer Diagnostics and Therapeutics Market. Request a sample to stay up-to-date on the main trends affecting this market: http://marketdataforecast.com/market-reports/north-america-cervical-cancer-diagnostics-and-therapeutics-market-830/request-sample
North America Cervical Cancer Diagnostics and Therapeutics Market: Segmentation
By diagnostics test • Pap smear test • HPV testing • Colposcopy • Cervical cancer biopsy
By methods • Molecular method • Cytopathological method • Physical method
By therapies • Surgery • Radiation therapy • Chemotherapy • Other therapies
By end-users • Hospitals • Laboratories • Independent physicians • Clinics • Other end-users
By Geography • North America o US o Canada
From simple data collation through secondary and primary research to ad-hoc research requests relating to specific information, we provide our services via customization. Get customization at http://marketdataforecast.com/market-reports/north-america-cervical-cancer-diagnostics-and-therapeutics-market-830/customize-report
North America Cervical Cancer Diagnostics and Therapeutics Market: Overview By diagnostic test, Pap smear test captured nearly half of the market share. It is expected to remain the market leader in the aforementioned forecast period because it is very efficient and economical. North America is the largest regional market. Increasing cases of cervical cancer, increased awareness and government support are the reasons behind this. US is the market leader in this region.
North America Cervical Cancer Diagnostics and Therapeutics Market: Key Players
Key players in the market include F.Hoffmann-La Roche Ltd, GlaxoSmithKline Pharmaceuticals Limited, Novartis International AG, Bristol-Myers Squibb, Eisai Co. Ltd, Biogen Idec. Other players in the market include ERYtech Pharma , Celgene Corporation, Genmab A/S, Cephalon Inc., Clavis Pharma, and Pfizer Inc.
About Market Data Forecast: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options.
For more information, kindly visit, www.marketdataforecast.com
Visit Market Data Forecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases
Market Data Forecast
Abhishek
+1-888- 702-9626
abhishek@marketdataforecast.com
Source: EmailWire.Com
|